NIH-funded research R01 grant

Understanding early signs of neurodegeneration in patients with sleep behavior disorders

Official title: Identification of Prodromal Neurodegeneration in Serotonergic-Induced REM sleep Behavior Disorder

Funded at University of Minnesota · NIH-10909338 · Data updated 2026-11-12

This study is looking at how REM sleep behavior disorder (RBD) might be linked to early signs of dementia in people who have started taking certain antidepressants, and it hopes to help identify warning signs like changes in color vision or mild memory issues that could mean a higher risk for conditions like Dementia with Lewy bodies or Parkinson's disease.

More REM Sleep Behavior Disorder research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Minnesota
NIH-funded
Lab location1 site (Minneapolis, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2028
Funding year2024
Award (this year)$774,788
NIH project number5R01AG075101-02
Project IDNIH-10909338 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults experiencing REM sleep behavior disorder, particularly those who have recently started serotonergic antidepressants.

Less likely to help

Patients who do not have REM sleep behavior disorder or are not on serotonergic medications may not benefit from this research.

What this research studies

This research investigates the connection between REM sleep behavior disorder (RBD) and early neurodegenerative changes, particularly in patients who have started serotonergic antidepressants. It aims to identify prodromal signs of dementia, such as impaired color vision and mild cognitive impairment, that may emerge in individuals with RBD. By analyzing these symptoms, the study seeks to better understand how RBD can indicate the risk of developing conditions like Dementia with Lewy bodies or Parkinson's disease. Patients will be monitored over time to assess the progression of symptoms and their relationship to neurodegeneration.

Why it matters

Potential benefit: If successful, this research could lead to earlier diagnosis and intervention for patients at risk of developing neurodegenerative disorders.

How similar studies have gone: Previous research has indicated that early signs of neurodegeneration can be linked to sleep disorders, suggesting that this approach may yield valuable insights.

Where this research is happening

  • University of Minnesota
    Minneapolis, United States
    Active

Researchers

  • Principal investigator: Howell, Michael J — University of Minnesota
  • Study coordinator: Howell, Michael J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.